Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quidel Cp (QDEL)

Quidel Cp (QDEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Quidel Cp 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 USA

P: 858-552-1100 F: 858-453-4338

Description:

Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.

Key Statistics

Overview:

Market Capitalization, $K 5,213,701
Shares Outstanding, K 42,319
Annual Sales, $ 1,662 M
Annual Net Income, $ 810,290 K
Last Quarter Sales, $ 809,200 K
Last Quarter Net Income, $ 470,130 K
60-Month Beta 0.08
% of Insider Shareholders 14.10%
% of Institutional Shareholders 81.52%
Float, K 36,352
% Float 85.90%

Growth:

1-Year Return 31.05%
3-Year Return 128.92%
5-Year Return 561.64%
5-Year Revenue Growth 747.23%
5-Year Earnings Growth 10,961.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 11.07 on 02/18/21
Next Earnings Date 05/05/21
Earnings Per Share ttm 19.55
EPS Growth vs. Prev Qtr 92.78%
EPS Growth vs. Prev Year 1,064.89%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

QDEL Ratios

Ratio
Price/Earnings ttm 6.56
Price/Earnings forward 25.82
Price/Earnings to Growth 0.19
Return-on-Equity % 100.31%
Return-on-Assets % 67.38%
Profit Margin % 48.76
Net Margin % 1.02
Debt/Equity 0.00
Price/Sales 3.27
Price/Cash Flow 5.94
Price/Book 4.05
Book Value/Share 31.68
Interest Coverage 109.14
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar